SUMMARY Clinical gout and renal failure was seen in a 9-year-old girl. The family tree showed that 9 out of 11 young females in three generations suffered from hyperuricaemia and normal (n = 1), or impaired (n =8), renal function. One set of twins occurred in each generation and there is only one living male subject. In members with renal failure there was no improvement in renal function after treatment of hyperuricaemia, and in 2 sisters oral contraceptives appeared to precipitate hypertension. This clinical picture may be more common than is generally realised because of failure to compare blood uric acid values with suitable age-and sex-matched controls. The evidence from this family suggests that hyperuricaemia preceded the development of renal failure.
Classical gout occurs most commonly in middle-aged men,1 and is extremely rare in premenopausal women or children. In children a specific metabolic abnormality resulting in gross uric acid over-productionsuch as the Lesch-Nyhan syndrome-can often be identified.2 Although at one time renal failure was common in gouty patients3 Berger and Yu4 could find no case in which death might be attributed to renal failure in 524 men with gout. Conversely, in renal failure from other causes, hyperuricaemia occurring as part of the general retention of nitrogenous waste is invariably mild even if there is severe reduction in glomerular filtration rate. Gout is rare as a primary cause of renal failure and accounts for only 08 8% in 69 400 European patients treated by dialysis (A J Wing, 1979, personal communication) .
In this paper a family is described with the unusual combination of precocious gout and progressively fatal renal disease occurring in young women. There is strong evidence to suggest that raised uric acid levels preceded the onset of the renal disease.
Patients and methods All biochemical results were obtained from routine analysis of blood samples in the hospital laboratory using SMA 12-60 colorimetric methods. Detailed investigations using a specific enzymatic method for uric acid are presented elsewhere. 56 Clinical features.
Case I This 9-year-old girl presented in 1961 with gout in the left big toe. Her blood urea concentration was 12-5 mmol/l (75 3 mg/100 ml) and blood uric acid 0 55 mmol/l (9.2 mg/100 ml), but the uric acid at another hospital had been found to be 0.78 mmol/l (13 mg/ 100 ml). She was treated with sulphinpyrazone in varying dosages between 1961 and 1967 when allopurinol was started, and on which she remains. Poor patient compliance probably explains the pronounced variation in the blood uric acid level during treatment (Fig. 1 The affected members of the family were traced back to I, 2 (Fig. 4) who was born in 1861 and married . .
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The father of the famiily (II, 3 in Fig. 4 The mother of the kindred lived to a healthy 80 years and there is no suggestion of gout or renal 3 Comparison of blood uric acid and creatinine failure in her kindred. The family history -thus levels in Case 4 and her second cousin showing marked similarity in the rate of change ofboth renalfunction and blood uric acid levels in two female members of the same family. since 1971 when she was 7-years old (Fig. 2) . She has had no symptoms apart from traces of proteinuria in 1975 and 1976. Blood levels for creatinine and uric acid were considered normal from 1971 to 1977 as were uric acid and creatinine clearances. The blood pressure was initially 90/65 mmHg and has remained constant. However, as with Case 4 blood creatinine and uric acid levels rose slowly from 1971 to 1976 (Fig. 2 ). An intravenous pyelogram in 1977 showed normal kidneys and normal urinary tract. Severe bleeding associated with grossly abnormal renal vasculature followed needle biopsy of the kidney and led to nephrectomy. However, creatinine clearance in 1978 was 104 ml/min. Allopurinol treatment was started after the renal biopsy and has continued. suggests a spontaneous mutation manifest in her husband (11, 3 in Fig. 4 ) born in 1884.
Histological investigation. Renal biopsy, performed in Case 3 (IV 1) when she was 30 years old and before the family history of gout had been recognised, showed intracapsular fibrosis in 5 out of 50 glomeruli, with foci of chronic cell infiltration and fibrosis in the interstitium. Mild chronic pyelonephritis was considered possible but the appearances were nonspecific. Tubular basement membrane thickening with patchy mild interstitial fibrosis were also seen in the biopsy in her daughter (Case 4; V, 2). The biopsies have now been re-examined in detail and will be reported elsewhere.7
Discussion
The single fact which initially distinguished this kindred was gout in the big toe in a young girl of 9. An aunt had already died 10 years earlier of 'nephritis', and the child's mother and the mother's identical twin sister were both being treated for gout and progressive renal disease which developed in their late twenties. The fact that the little girl's own non-identical twin was also hyperuricaemic, and that renal function was varyingly reduced in both, served to focus attention on the coexisting abnormality of uric acid metabolism which had hitherto escaped notice. Alport's syndrome had been diagnosed in the family but clinical features in recently affected members do not support this.
Failure to recognise the severity of the hyperuricaemia in these young women was partly due to comparing their blood uric acid levels with a range for normal adults issued by the hospital laboratory. Thus laboratory results should be compared with appropriate control values.
These investigations confirm a repetitive abnormality of uric acid metabolism associated with a high incidence of renal disease of varying degree. The family study suggests an autosomal dominant disease which has, by chance, affected only females in a family with few males. Alternatively, II 3 (Fig. 4) could have been a mosaic for an X-linked somatic mutation, and this would explain the absence of the disease in one of his daughters.
The high incidence of twins in affected family members is remarkable and was noted by us in another study of families with a similar history of precocious gout and progressive renal disease.6 There is evidence to support the possibility that these young, gouty patients may form a distinct subgroup or groups within the gouty population which is almost certainly more common than currently realised. For instance, several recent surveys of large gouty populations have confirmed the rarity of gouty women as well as confirming the fairly good renal function in most of today's gouty subjects-a group predominantly middle aged and male.' 4 Within each survey however, a few subjects have been identified in whom gout developed before age 40 and in whom it was associated with severe renal disease, and such surveys have shown a high incidence of females.
The nature and origin of the defect in this present kindred remains unknown. The close similarity in the development of the disease (around puberty) in one generation and between generations suggests a process common to all affected members of the family. Although urinary tract infection was noted early in the cousin of Case 1, the disease was by then well established and urinary tract infection has not been a recurrent clinical problem, nor was it present in family members who were equally badly affected. Primary renal disease-such as in Bartter 
